#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5250387	F	Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 2 days by CCK8 assay	Homo sapiens	36	ALA5247625	cell-based format	Scientific Literature
2.	ALA5250390	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as increase in BCR-ABL degradation at 5 nM by Western blotting analysis	Homo sapiens	19	ALA5247625	cell-based format	Scientific Literature
3.	ALA5250391	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as increase in BCR-ABL degradation at 100 nM by Western blotting analysis	Homo sapiens	19	ALA5247625	cell-based format	Scientific Literature
4.	ALA5250392	A	Apparent permeability in human Caco-2 cells incubated for 120 mins by LC-MS/MS analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
5.	ALA5250393	B	Binding affinity to recombinant ABL (unknown origin)	Homo sapiens	1	ALA5247625	single protein format	Scientific Literature
6.	ALA5250394	F	Antiproliferative activity against human U-937 cells assessed as inhibition of cell growth incubated for 2 days by CCK8 assay	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
7.	ALA5250395	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as increase in BCR-ABL degradation incubated for 16 hrs by Western blotting analysis	Homo sapiens	3	ALA5247625	cell-based format	Scientific Literature
8.	ALA5250396	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as increase in c-ABL degradation incubated for 16 hrs by Western blotting analysis	Homo sapiens	3	ALA5247625	cell-based format	Scientific Literature
9.	ALA5250397	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as increase in BCR-ABL degradation at 0.3 to 100 nM incubated for 16 hrs by Western blotting analysis relative to control	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
10.	ALA5250398	B	Inhibition of BCR-ABL phosphorylation at Tyr245 residue in human K562 cells at 0.3 to 100 nM incubated for 16 hrs by Western blotting analysis	Homo sapiens	2	ALA5247625	cell-based format	Scientific Literature
11.	ALA5250399	B	Inhibition of STAT5 phosphorylation at Tyr694 residue in human K562 cells at 0.3 to 100 nM incubated for 16 hrs by Western blotting analysis	Homo sapiens	2	ALA5247625	cell-based format	Scientific Literature
12.	ALA5250400	B	Inhibition of CRKL phosphorylation at Tyr207 residue in human K562 cells at 0.3 to 100 nM incubated for 16 hrs by Western blotting analysis	Homo sapiens	2	ALA5247625	cell-based format	Scientific Literature
13.	ALA5250401	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 100 nM by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
14.	ALA5250402	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as BCR-ABL turnover rate in presence of cycloheximide by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
15.	ALA5250403	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as c-ABL turnover rate in presence of cycloheximide by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
16.	ALA5250404	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 100 nM pretreated with lenalidomide for 2 hrs followed by compound addition measured after 8 hrs by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
17.	ALA5250405	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 100 nM pretreated with asciminib for 2 hrs followed by compound addition measured after 8 hrs by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
18.	ALA5250406	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 100 nM pretreated with MLN4924 for 2 hrs followed by compound addition measured after 8 hrs by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
19.	ALA5250407	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as induction of c-ABL degradation at 100 nM pretreated with lenalidomide for 2 hrs followed by compound addition measured after 8 hrs by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature
20.	ALA5250408	B	Protac activity at CRBN/BCR-ABL in human K562 cells assessed as induction of c-ABL degradation at 100 nM pretreated with asciminib for 2 hrs followed by compound addition measured after 8 hrs by Western blotting analysis	Homo sapiens	1	ALA5247625	cell-based format	Scientific Literature